Skip to main content

Treatment Clinical Trials for Prostate Cancer

Review the prostate cancer treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 251-275 of 303

177^Lu-PSMA-617 in Combination with Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Status: Active
Location: City of Hope Comprehensive Cancer Center, Duarte, California
Stereotactic Body Radiation Therapy for the Treatment of Patients with Advanced Prostate Cancer, PRORAD-5 Trial
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Cabozantinib in Combination with Lutetium-177 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, CaboLu Study
Status: Active
Location: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
pTVG-HP DNA Vaccine + Nivolumab + Targeted Radiation Therapy to Resistant Lesions for the Treatment of Biochemically Recurrent, Oligometastatic Prostate Cancer
Status: Active
Location: University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin
CBP-1019 with FOLFOX with or without Bevacizumab, Pembrolizumab, or Enzalutamide for the Treatment of Metastatic Solid Tumors of Epithelial Origin
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Tumor Treating Fields Therapy (NovoTTF™-200M and NovoTTF-200A Systems) for the Treatment of Refractory Spinal Metastasis
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Status: Active
Location: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
A Study of MGC026 in Participants With Advanced Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Pre-Surgical Tirzepatide-Assisted Weight Loss for the Treatment of Overweight and Obese Men with Diabetes and Prostate Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Differences in Immunological Effects of Vitamin D Replacement among African American Prostate Cancer Patients with Localized versus Metastatic Disease
Status: Active
Location: 2 locations
4AP for the Treatment of Nerve Injury from Retropubic Prostatectomy in Patients with Localized Prostate Cancer
Status: Active
Location: Banner University Medical Center - Tucson, Tucson, Arizona
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men with Localized Prostate Cancer on Active Surveillance
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
Discontinuation of Standard LHRH Agonist Therapy in Elderly Prostate Cancer Patients
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
Cone-Beam Computed Tomography-Based Adaptive Stereotactic Body Radiation Therapy for the Treatment of Intermediate- and Favorable High-Risk Prostate Cancer, DE-CART Trial
Status: Active
Location: Fox Chase Cancer Center, Philadelphia, Pennsylvania
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Focal Therapy (Transvesical Single-Port Robotic Partial Prostatectomy versus High-Intensity Focused Ultrasound) for the Treatment of Patients with Prostate Cancer
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
Focal Ablation with Focal Cryotherapy or High Intensity Frequency Ultrasound for the Treatment of Men with Localized Prostate Cancer
Status: Active
Location: University of California Davis Comprehensive Cancer Center, Sacramento, California
Image-Guidance and Online Adaptation with Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Computed Tomography-Guided Stereotactic Body Radiation Therapy with Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Two-Fraction High Dose Rate Brachytherapy Delivered Three Hours Apart for Localized Prostate Cancer
Status: Active
Location: University of California San Francisco, San Francisco, California
Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
Status: Active
Location: See ClinicalTrials.gov